Gilham, D.; Wasiak, S.; Rakai, B.D.; Fu, L.; Tsujikawa, L.M.; Sarsons, C.D.; Carestia, A.; Lebioda, K.; Johansson, J.O.; Sweeney, M.;
et al. Apabetalone Downregulates Fibrotic, Inflammatory and Calcific Processes in Renal Mesangial Cells and Patients with Renal Impairment. Biomedicines 2023, 11, 1663.
https://doi.org/10.3390/biomedicines11061663
AMA Style
Gilham D, Wasiak S, Rakai BD, Fu L, Tsujikawa LM, Sarsons CD, Carestia A, Lebioda K, Johansson JO, Sweeney M,
et al. Apabetalone Downregulates Fibrotic, Inflammatory and Calcific Processes in Renal Mesangial Cells and Patients with Renal Impairment. Biomedicines. 2023; 11(6):1663.
https://doi.org/10.3390/biomedicines11061663
Chicago/Turabian Style
Gilham, Dean, Sylwia Wasiak, Brooke D. Rakai, Li Fu, Laura M. Tsujikawa, Christopher D. Sarsons, Agostina Carestia, Kenneth Lebioda, Jan O. Johansson, Michael Sweeney,
and et al. 2023. "Apabetalone Downregulates Fibrotic, Inflammatory and Calcific Processes in Renal Mesangial Cells and Patients with Renal Impairment" Biomedicines 11, no. 6: 1663.
https://doi.org/10.3390/biomedicines11061663
APA Style
Gilham, D., Wasiak, S., Rakai, B. D., Fu, L., Tsujikawa, L. M., Sarsons, C. D., Carestia, A., Lebioda, K., Johansson, J. O., Sweeney, M., Kalantar-Zadeh, K., & Kulikowski, E.
(2023). Apabetalone Downregulates Fibrotic, Inflammatory and Calcific Processes in Renal Mesangial Cells and Patients with Renal Impairment. Biomedicines, 11(6), 1663.
https://doi.org/10.3390/biomedicines11061663